Nicoletta Staropoli

Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients

Cirino Botta, Vito Barbieri, Domenico Ciliberto et al. · Cancer Biology & Therapy · 2013 · 92 citations · Full text

Inflammatory Lung Disease, Baseline Predicts, Lung Inflammation +18

Nanoparticle Albumin Bound Paclitaxel in the Treatment of Human Cancer: Nanodelivery Reaches Prime-Time?

Iole Cucinotto, Lucia Fiorillo, S Gualtieri et al. · Journal of Drug Delivery · 2013 · 91 citations · Full text

Nanoparticles, Engineering, Biomedical Engineering +17

Sacituzumab Govitecan for the treatment of advanced triple negative breast cancer patients: a multi-center real-world analysis

Roberta Caputo, Giuseppe Buono, Michela Piezzo et al. · Frontiers in Oncology · 2024 · 61 citations · Full text

Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study

Pierfrancesco Tassone, Maria Teresa Di Martino, Mariamena Arbitrio et al. · Journal of Hematology & Oncology · 2023 · 60 citations · Full text

Network meta-analysis of randomized trials in multiple myeloma: efficacy and safety in relapsed/refractory patients

Cirino Botta, Domenico Ciliberto, Marco Rossi et al. · Blood Advances · 2017 · 57 citations · Full text

Cancer Management, Immunology, Pharmacotherapy +17